.jpeg)
Effective treatment options are scarce, making precise biomarkers and multidisciplinary evaluation essential for identifying personalized treatment opportunities.
The wide variety of rare diseases leads to an average diagnostic delay of 5–7 years, often missing the critical window for effective treatment.
The same disease can manifest very differently across patients, making it challenging for traditional testing to accurately subtype and assess.
Chronic discomfort impacts your physical and mental well-being and work, requiring a personalized improvement plan.















